Salvatore Martini
Overview
Explore the profile of Salvatore Martini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pisaturo M, Onorato L, Russo A, Martini S, Chiodini P, Signoriello S, et al.
Clin Microbiol Infect
. 2020 Oct;
27(1):28-35.
PMID: 33031949
Objectives: Several attempts have been made to test different drug-sparing strategies to reduce the drug-burden and drug-related toxicities. The objective of this meta-analysis was to evaluate the relative risk (RR)...
12.
Alessio L, Onorato L, Sangiovanni V, Borrelli F, Manzillo E, Esposito V, et al.
Antivir Ther
. 2020 Apr;
25(4):193-201.
PMID: 32314978
Background: The aim of the present study was to evaluate in HIV-infected patients treated with a direct-acting antiviral agent (DAA)-based regimen the variables associated with sustained virological response (SVR) and...
13.
Buonomo A, Scotto R, Coppola C, Pinchera B, Viceconte G, Rapillo C, et al.
Medicine (Baltimore)
. 2020 Feb;
99(6):e18948.
PMID: 32028404
The effectiveness of direct-acting antivirals (DAAs) against hepatitis C virus (HCV) infection is ascertained. However, some authors raised the issue of an increased incidence of de novo hepatocellular carcinoma (HCC)...
14.
Sagnelli C, Pisaturo M, Calo F, Martini S, Sagnelli E, Coppola N
World J Gastroenterol
. 2019 Jul;
25(26):3299-3312.
PMID: 31341357
Reactivation of hepatitis B virus (HBV) replication is characterized by increased HBV-DNA serum values of about 1 log or by HBV DNA turning positive if previously undetectable in serum, possibly...
15.
Alteri C, Scutari R, Stingone C, Maffongelli G, Brugneti M, Falasca F, et al.
J Clin Virol
. 2019 Jun;
117:61-67.
PMID: 31229934
Background: Accurate quantification of total HIV-DNA and residual-viremia by sensitive assays is extremely useful to optimize monitoring of ART-treated patients. Objectives: To evaluate the performances of two ddPCR-based assays for...
16.
Gentile I, Buonomo A, Coppola C, Staiano L, Amoruso D, Saturnino M, et al.
New Microbiol
. 2019 Apr;
42(2):94-100.
PMID: 31034085
Approximately 71 million people are chronically infected with HCV worldwide. Recently, interferonfree therapies effective against HCV became available and nowadays, therapeutic strategies include a combination of two or three drugs...
17.
Coppola N, Portunato F, Buonomo A, Staiano L, Scotto R, Pinchera B, et al.
J Nephrol
. 2019 Apr;
32(5):763-773.
PMID: 30977055
Background And Aim: The impact of directly acting antiviral agent (DAA) regimens on renal function is not well defined and quite controversial. We evaluated the effect of DAAs on kidney...
18.
Pisaturo M, Starace M, Minichini C, De Pascalis S, Macera M, Occhiello L, et al.
Antivir Ther
. 2019 Feb;
24(7):485-493.
PMID: 30758299
Background: This real-world clinical setting study characterized the virological patterns in genotype-1 patients failing interferon (IFN)-free regimens and evaluated the efficacy of re-treatment. Methods: A total of 73 consecutive patients...
19.
Gentile I, Scotto R, Coppola C, Staiano L, Amoruso D, De Simone T, et al.
Hepatol Int
. 2018 Dec;
13(1):66-74.
PMID: 30523552
Background: Direct-acting antivirals (DAAs) are safe and effective for the treatment of HCV infection. However, data regarding their efficacy in patients with Child-Pugh B cirrhosis are scarce and their capability...
20.
Pisaturo M, Di Caprio G, Calo F, Portunato F, Martini S, Coppola N
Expert Rev Anti Infect Ther
. 2018 Jul;
16(8):611-624.
PMID: 30058401
HBV reactivation (HBVr) in patients undergoing immunosuppressive therapy is a well-known event. While there are clear directives on the management of current or resolved HBV infection in onco-hematological diseases, there...